Recombinant human hyaluronidase/bisphosphonates (Halozyme)
重组人透明质酸酶/双膦酸盐
Report date: 2022/03/14 17:16:59
Base Information
Drug NameRecombinant human hyaluronidase/bisphosphonates (Halozyme)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHalozyme Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHalozyme Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A